CD247 and brain neoplasm: For treatment, we used our previously published second-generation EGFRvIII CAR T (co-stimulated with 4-1BB and activation through CD3ζ) in both subcutaneous and orthotopic brain tumor xenografts in NSG mice (Figure 4A) (6, 47, 48).